We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

75 hedge funds and large institutions have $434M invested in Coherus Oncology in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

357% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 7

343% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 7

96% more capital invested

Capital invested by funds: $222M → $434M (+$213M)

47% more funds holding

Funds holding: 51 → 75 (+24)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

33% less call options, than puts

Call options by funds: $175K | Put options by funds: $260K

Holders
75
Holders Change
+24
Holders Change %
+47.06%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
31
Increased
32
Reduced
7
Closed
7
Calls
$175K
Puts
$260K
Net Calls
-$85K
Net Calls Change
-$85K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$47.4M
2
TCP
Tourbillon Capital Partners
New York
+$18.1M
3
TCIM
TIAA CREF Investment Management
New York
+$17.8M
4
BFA
BlackRock Fund Advisors
California
+$15.6M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$10.4M

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$4.97M
2
RCM
RA Capital Management
Massachusetts
-$4.42M
3
Millennium Management
Millennium Management
New York
-$3.63M
4
MIM
Monashee Investment Management
Massachusetts
-$3.06M
5
PAM
Panagora Asset Management
Massachusetts
-$1.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$2.74M +$963K +38,084 +67%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$2.5M +$633K +25,023 +41%
CCMU
28
Cheyne Capital Management (UK)
United Kingdom
$2.45M +$2.14M +84,778 New
BIM
29
BlackRock Investment Management
Delaware
$2.41M +$2.1M +83,246 New
CWG
30
C WorldWide Group
Denmark
$1.73M +$1.52M +60,000 New
Charles Schwab
31
Charles Schwab
California
$1.36M +$701K +27,711 +144%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$1.25M +$775K +30,669 +247%
Renaissance Technologies
33
Renaissance Technologies
New York
$1.18M +$1.03M +40,907 New
CS
34
Candriam SCA
Luxembourg
$1.16M – – –
AA
35
ALPS Advisors
Colorado
$1.08M +$948K +37,511 New
TA
36
Teachers Advisors
New York
$993K +$704K +27,858 +429%
AllianceBernstein
37
AllianceBernstein
Tennessee
$962K +$677K +26,800 +412%
SM
38
Sabby Management
Florida
$867K +$758K +30,000 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$746K +$653K +25,830 New
FAM
40
Fred Alger Management
New York
$723K +$632K +25,000 New
Deutsche Bank
41
Deutsche Bank
Germany
$711K +$623K +24,652 +246,520%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$575K +$503K +19,885 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$504K +$441K +17,435 New
SAM
44
Sectoral Asset Management
Quebec, Canada
$462K +$83.9K +3,318 +26%
BJ
45
BlackRock Japan
Japan
$441K +$385K +15,246 New
NFA
46
Nationwide Fund Advisors
Ohio
$440K +$259K +10,236 +205%
AIG
47
American International Group
New York
$399K +$241K +9,541 +223%
BA
48
BlackRock Advisors
Delaware
$363K +$318K +12,566 New
VOYA Investment Management
49
VOYA Investment Management
Georgia
$327K +$286K +11,331 New
BCM
50
Bourgeon Capital Management
Connecticut
$289K +$253K +10,000 New
1
2
3 4

CHRS Hedge Fund Activity: Q2 2015 in Review

75 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q2 2015, worth a combined $434M — up 96% from $222M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new CHRS positions and 7 closed out — a net gain of 24 holders — while 32 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $47.4M. The largest seller was EAM Investors, exiting entirely with an estimated $4.97M sold.

  • 75 institutional investors held Coherus Oncology (CHRS) as of Q2 2015, up from 51 in Q1 2015.
  • Funds reported $434M of Coherus Oncology stock for Q2 2015, up 96% quarter-over-quarter.
  • 31 funds opened new Coherus Oncology positions in Q2 2015 and 7 closed out, a net change of +24 holders.
  • The largest Coherus Oncology buyer in Q2 2015 was Fidelity Investments, an estimated $47.4M added.
  • The largest Coherus Oncology seller in Q2 2015 was EAM Investors, an estimated $4.97M sold.

Based on aggregated 13F filings for Q2 2015.